Particle.news
Download on the App Store

French Team Finds Brain Cells That Clear Tau, Pointing to New Alzheimer’s Targets

The study reframes Tau buildup as a clearance failure involving tanycytes, with clinical promise subject to validation.

Overview

  • Inserm and CHU de Lille researchers showed in mice that tanycytes move Tau from brain to blood, enabling its clearance.
  • Post-mortem analyses found these cells markedly damaged in people who had Alzheimer’s, consistent with impaired Tau removal.
  • The discovery, led by Vincent Prévot, was published March 9 in the journal Cell Press Blue.
  • The work suggests two avenues now under study: biomarkers of tanycyte dysfunction for earlier detection and therapies to protect or repair these cells.
  • Monoclonal antibodies that target abnormal proteins are already used in the United States, and the proposed tanycyte-focused strategy would be complementary.